Rates of complete diagnostic testing for patients with acute myeloid leukemia

Cancer Medicine

Volumn 4, Issue 4, 2015, Pages 519-522

  Lin, Tara L ^a   Williams, Travis ^a   He, Jianghua ^a   Aljitawi, Omar S ^a   Ganguly, Siddhartha ^a   Abhyankar, Sunil ^a   Fleming, Allan ^a   Male, Heather ^a   Mcguirk, Joseph P ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

AML; Molecular testing; Practice patterns

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; CD135 ANTIGEN; CORE BINDING FACTOR; NUCLEOPHOSMIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER PATIENT; CYTOGENETICS; DIAGNOSTIC TEST; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; ONCOGENE C KIT; PATIENT RISK; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; WORLD HEALTH ORGANIZATION; DNA MUTATIONAL ANALYSIS; EARLY CANCER DIAGNOSIS; KANSAS; LEUKEMIA, MYELOID, ACUTE; MOLECULAR DIAGNOSIS; STATISTICS AND NUMERICAL DATA;

DNA MUTATIONAL ANALYSIS; EARLY DETECTION OF CANCER; HUMANS; KANSAS; LEUKEMIA, MYELOID, ACUTE; MOLECULAR DIAGNOSTIC TECHNIQUES; RETROSPECTIVE STUDIES;

EID: 84984870856     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.406     Document Type: Article

References (15)

1. O'Donnell, M. R., M. S. Tallman, C. N. Abboud, J. K. Altman, F. R. Appelbaum, D. A. Arber, et al. 2013. Acute myeloid leukemia. J. Natl. Compr. Cancer Netw. 11:1047-1055.
2. Pastore, F., A. Dufour, T. Benthaus, K. H. Metzeler, K. S. Maharry, S. Schneider, et al. 2014. Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal AML (PINA). J. Clin. Oncol. 32:1586-1594.
3. Santamaría, C. M., M. C. Chillón, R. García-Sanz, C. Perez, M. D. Caballero, F. Ramos, et al. 2009. Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia. Blood 114:148-152.
4. Paschka, P., G. Marcucci, A. S. Ruppert, K. Mrozek, H.Chen, R. A. Kittles, et al. 2006. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. J. Clin. Oncol. 24:3904-3911.
5. Riera, L., F. Marmont, D. Toppino, C. Frairia, F. Sismondi, E. Audisio, et al. 2013. Core binding factor acute myeloid leukaemia and c-KIT mutations. Oncol. Rep. 29:1867-1872.
6. Röllig, C., M. Bornhäuser, C. Thiede, F. Taube, M. Kramer, B. Mohr, et al. 2011. Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system. J. Clin. Oncol. 29:2758-2765.
7. Vardiman, J. W., J. Thiele, D. A. Arber, R. D. Brunning, M. J. Borowitz, A. Porwit, et al. 2009. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114:937-951.
8. Hillner, B. E., T. J. Smith, and C. E. Desch 2000. Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J. Clin. Oncol. 18:2327-2340.
9. Merkow, R. P., D. J. Bentrem, J. W. Chung, J. L. Paruch, C. Y. Ko, and K. Y. Bilimoria 2013. differences in patients, surgical complexity, and outcomes after cancer surgery at National Cancer Institute-designated cancer centers compared to other hospitals. Med. Care 51:606-613. doi: 10.1097/MLR.0b013e3182928f44.
10. Birkmeyer, N. J., P. P. Goodney, T. A. Stukel, B. E. Hillner, and K. D. Birkmeyer 2005. Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer 103:435-441.
11. Paulson, E. C., N. Mitra, S. Sonnad, K. Armstrong, C. Wirtalla, R. R. Kelz, et al. 2008. National Cancer Institute designation predicts improved outcomes in colorectal cancer surgery. Ann. Surg. 248:675-686.
12. Friese, C. R., C. C. Earle, J. H. Silber, and L. H. Aiken 2010. Hospital characteristics, clinical severity, and outcomes for surgical oncology patients. Surgery 147:602-609.
13. Stiller, C., S. Benjamin, R. A. Cartwright, J. V. Clough, D. W. Gorst, M. E. Kroll, et al. 1999. Patterns of care and survival for adolescents and young adults with acute leukaemia-a population-based study. Br. J. Cancer 79:658.
14. Horowitz, M., D. Przepiorka, R. Champlin, R. P. Gale, A. Gratwohl, R. H. Herzig, et al. 1992. Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers? [see comments]. Blood 79:2771-2774.
15. Pease, D., J. A. Ross, P. L. Nguyen, B. Hirsch, A. Cioc, A. R. Smith, et al. 2013. Differences in community and academic practice patterns for newly diagnosed myelodysplastic syndromes (MDS) patients in minnesota: a population based study. Blood 122:2798.